Lantheus Holdings Inc
LNTH76.350USD
+2.110+2.84%
Fechamento 03/26, 16:00（ET）Cotações atrasadas em 15 min
2.02BValor de mercado
22.06P/L TTM
Mais detalhes de Lantheus Holdings Inc Empresa
Lantheus Holdings, Inc. is a radiopharmaceutical-focused company engaged in delivering science to enable clinicians to find, fight and follow diseases to deliver patient outcomes. The Company classifies its products in three categories: Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships. Radiopharmaceutical Oncology diagnostics and therapeutics help healthcare professionals (HCPs) find, fight and follow cancer, with a focus on prostate cancer. Precision Diagnostic products assist HCPs to find and follow diseases, with a focus on cardiology. Strategic Partnerships focus on enabling precision medicine through the use of biomarker solutions, digital solutions, and radiotherapeutic platforms. Its commercial products include PYLARIFY, DEFINITY, TechneLite, Neuraceq, and others. Its clinical candidates include LNTH-2404, NAV-4694, and PNT2002, among others. The Neuraceq (florbetaben F18 injection) is an F-18 PET imaging agent for Alzheimer’s disease.
Informações de Lantheus Holdings Inc
Código da empresaLNTH
Nome da EmpresaLantheus Holdings Inc
Data de listagemJun 25, 2015
CEOMarkison (Brian A)
Número de funcionários808
Tipo de títulosOrdinary Share
Fim do ano fiscalJun 25
Endereço331 Treble Cove Road
CidadeNORTH BILLERICA
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal01862
Telefone19786718001
Sitehttps://www.lantheus.com/
Código da empresaLNTH
Data de listagemJun 25, 2015
CEOMarkison (Brian A)
Executivos da empresa Lantheus Holdings Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Mary Anne Heino
Ms. Mary Anne Heino
Executive Chairman of the Board, Interim Executive Officer
Executive Chairman of the Board, Interim Executive Officer
589.20K
-1.67%
Mr. Brian A. Markison
Mr. Brian A. Markison
Chief Executive Officer, Director
Chief Executive Officer, Director
232.42K
+26.10%
Dr. Jean-Claude Provost, M.D.
Dr. Jean-Claude Provost, M.D.
Chief Scientific Officer
Chief Scientific Officer
38.84K
-46.09%
Dr. James H. (Jim) Thrall
Dr. James H. (Jim) Thrall
Independent Director
Independent Director
35.74K
+7.10%
Dr. Gerard Ber, Ph.D.
Dr. Gerard Ber, Ph.D.
Independent Director
Independent Director
23.36K
+9.16%
Ms. Minnie Baylor-Henry, J.D.
Ms. Minnie Baylor-Henry, J.D.
Independent Director
Independent Director
9.90K
+25.63%
Dr. Phuong Khanh (P. K.) Morrow, M.D.
Dr. Phuong Khanh (P. K.) Morrow, M.D.
Independent Director
Independent Director
3.10K
+81.84%
Mr. Samuel R. (Sam) Leno
Mr. Samuel R. (Sam) Leno
Independent Director
Independent Director
--
--
Ms. Julie H. Mchugh
Ms. Julie H. Mchugh
Lead Independent Director
Lead Independent Director
--
--
Mr. Gary John Pruden
Mr. Gary John Pruden
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Mary Anne Heino
Ms. Mary Anne Heino
Executive Chairman of the Board, Interim Executive Officer
Executive Chairman of the Board, Interim Executive Officer
589.20K
-1.67%
Mr. Brian A. Markison
Mr. Brian A. Markison
Chief Executive Officer, Director
Chief Executive Officer, Director
232.42K
+26.10%
Dr. Jean-Claude Provost, M.D.
Dr. Jean-Claude Provost, M.D.
Chief Scientific Officer
Chief Scientific Officer
38.84K
-46.09%
Dr. James H. (Jim) Thrall
Dr. James H. (Jim) Thrall
Independent Director
Independent Director
35.74K
+7.10%
Dr. Gerard Ber, Ph.D.
Dr. Gerard Ber, Ph.D.
Independent Director
Independent Director
23.36K
+9.16%
Ms. Minnie Baylor-Henry, J.D.
Ms. Minnie Baylor-Henry, J.D.
Independent Director
Independent Director
9.90K
+25.63%
Detalhamento da receita
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
PYLARIFY
240.62M
0.00%
DEFINITY
81.78M
0.00%
TechneLite
21.13M
0.00%
Neuraceq
20.44M
0.00%
Strategic partnerships and other
13.71M
0.00%
Other precision diagnostics
6.34M
0.00%
Os dados relevantes ainda não foram divulgados pela empresa.
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
PYLARIFY
240.62M
0.00%
DEFINITY
81.78M
0.00%
TechneLite
21.13M
0.00%
Neuraceq
20.44M
0.00%
Strategic partnerships and other
13.71M
0.00%
Other precision diagnostics
6.34M
0.00%
Distribuição de ações
Atualizado em: qui, 19 de fev
Atualizado em: qui, 19 de fev
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
11.09%
The Vanguard Group, Inc.
10.26%
Janus Henderson Investors
8.78%
Farallon Capital Management, L.L.C.
8.35%
Fidelity Management & Research Company LLC
4.71%
Outro
56.79%
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
11.09%
The Vanguard Group, Inc.
10.26%
Janus Henderson Investors
8.78%
Farallon Capital Management, L.L.C.
8.35%
Fidelity Management & Research Company LLC
4.71%
Outro
56.79%
Tipos de investidores
Investidores
Proporção
Investment Advisor
50.33%
Investment Advisor/Hedge Fund
35.54%
Hedge Fund
15.49%
Research Firm
4.31%
Individual Investor
2.63%
Sovereign Wealth Fund
1.81%
Pension Fund
1.60%
Bank and Trust
0.71%
Family Office
0.12%
Participação acionária institucional
Atualizado em: qui, 1 de jan
Atualizado em: qui, 1 de jan
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q4
1032
71.64M
108.04%
-15.51M
2025Q3
1018
78.96M
119.07%
-8.67M
2025Q2
1039
82.20M
120.88%
-4.84M
2025Q1
1066
83.20M
120.27%
-2.89M
2024Q4
1033
78.65M
114.86%
-4.64M
2024Q3
1003
73.69M
106.06%
-7.92M
2024Q2
959
71.82M
103.63%
-10.29M
2024Q1
912
71.21M
103.87%
-11.25M
2023Q4
868
73.50M
107.32%
-9.24M
2023Q3
828
74.80M
109.31%
-3.81M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
BlackRock Institutional Trust Company, N.A.
7.29M
11%
-208.45K
-2.78%
Sep 30, 2025
The Vanguard Group, Inc.
6.92M
10.44%
+100.16K
+1.47%
Sep 30, 2025
Janus Henderson Investors
6.68M
10.08%
-254.25K
-3.66%
Sep 30, 2025
Farallon Capital Management, L.L.C.
3.48M
5.24%
+161.00K
+4.85%
Sep 30, 2025
Fidelity Management & Research Company LLC
3.10M
4.68%
-1.03M
-24.93%
Sep 30, 2025
State Street Investment Management (US)
2.50M
3.77%
-61.59K
-2.41%
Sep 30, 2025
Geode Capital Management, L.L.C.
1.75M
2.65%
-22.43K
-1.26%
Sep 30, 2025
Reinhart Partners, LLC
1.35M
2.03%
-55.90K
-3.98%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
1.37M
2.07%
-12.04K
-0.87%
Sep 30, 2025
Swedbank Robur Fonder AB
1.23M
1.85%
--
--
Sep 30, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
State Street SPDR S&P Health Care Equipment ETF
1.96%
Invesco S&P MidCap 400 GARP ETF
1.69%
First Trust Small Cap US Equity Select ETF
1.07%
VictoryShares Small Cap Free Cash Flow ETF
0.93%
Invesco S&P MidCap 400 Pure Growth ETF
0.74%
Distillate Small/Mid Cash Flow ETF
0.66%
Pacer US Small Cap Cash Cows ETF
0.56%
Gotham 1000 Value ETF
0.5%
Invesco S&P MidCap Quality ETF
0.47%
Pacer US Cash Cows Growth ETF
0.47%
Ver Mais
State Street SPDR S&P Health Care Equipment ETF
Proporção1.96%
Invesco S&P MidCap 400 GARP ETF
Proporção1.69%
First Trust Small Cap US Equity Select ETF
Proporção1.07%
VictoryShares Small Cap Free Cash Flow ETF
Proporção0.93%
Invesco S&P MidCap 400 Pure Growth ETF
Proporção0.74%
Distillate Small/Mid Cash Flow ETF
Proporção0.66%
Pacer US Small Cap Cash Cows ETF
Proporção0.56%
Gotham 1000 Value ETF
Proporção0.5%
Invesco S&P MidCap Quality ETF
Proporção0.47%
Pacer US Cash Cows Growth ETF
Proporção0.47%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
